palmidrol has been researched along with oxazolidin-2-one in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Hu, T; Li, Y; Lin, F; Liu, X; Lu, C; Qiu, Y; Ren, J; Wu, K; Wu, Y; Xiang, L; Xiu, Y; Yang, Y; Zhou, P | 1 |
Hu, X; Li, F; Li, Y; Lin, K; Qiu, Y; Ren, J; Wang, C; Xiu, Y; Xu, S; Zhao, S | 1 |
Hu, T; Li, Y; Lu, C; Qiu, Y; Ren, J; Xu, Y; Zhou, P | 1 |
3 other study(ies) available for palmidrol and oxazolidin-2-one
Article | Year |
---|---|
N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Cartilage; Cells, Cultured; Chondrocytes; Ethanolamines; Injections, Intra-Articular; Injections, Intraperitoneal; Interleukin-6; Knee Joint; Male; Matrix Metalloproteinase 13; Osteoarthritis; Oxazolidinones; Pain; Palmitic Acids; PPAR alpha; Pyrrolidines; Rats, Sprague-Dawley; Spinal Cord | 2019 |
Palmitoylethanolamide (PEA) reduces postoperative adhesions after experimental strabismus surgery in rabbits by suppressing canonical and non-canonical TGFβ signaling through PPARα.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ethanolamines; Fibrosis; HEK293 Cells; Humans; Male; MAP Kinase Kinase Kinases; Mice; NIH 3T3 Cells; Oxazolidinones; Palmitic Acids; Postoperative Complications; PPAR alpha; Rabbits; Strabismus; Tissue Adhesions | 2021 |
NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI).
Topics: Amides; Amidohydrolases; Animals; Blood-Brain Barrier; Brain Injuries, Traumatic; Cell Line; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Ethanolamines; Female; Male; Mice, Inbred C57BL; Mice, Knockout; Neurons; Neuroprotective Agents; Neutrophils; Oxazolidinones; Palmitic Acids; PPAR alpha | 2021 |